Keymed Biosciences anuncia los datos de un ensayo clínico de Stapokibart para la dermatitis atópica ...Middle East

- Keymed Biosciences anuncia los datos de eficacia y seguridad a largo plazo de un ensayo clínico de fase III de Stapokibart para el tratamiento de la dermatitis atópica de moderada a grave CHENGDU, China, 3 de junio, 2024 /PRNewswire/ -- Keymed Biosciences Inc. (HKEX: 02162) anunció hoy...

Hence then, the article about keymed biosciences anuncia los datos de un ensayo clinico de stapokibart para la dermatitis atopica was published today ( Monday 03/06/2024 - 08:17 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Keymed Biosciences anuncia los datos de un ensayo clínico de Stapokibart para la dermatitis atópica )

Also on site :

• Police respond to incident at property in Dudley as residents 'spot armed police' in street
• Donald Trump& 039;s Niece, Mary, Reveals Secret Wedding—& 039;I Married Her& 039;
• Sinkhole on East Franklin Street Closes Lanes; Chapel Hill Urges for Detours